141 related articles for article (PubMed ID: 24491219)
1. Lipocalin-2, A-FABP and inflammatory markers in relation to flow-mediated vasodilatation in patients with essential hypertension.
Park CG; Choi KM
Clin Exp Hypertens; 2014; 36(7):478-83. PubMed ID: 24491219
[TBL] [Abstract][Full Text] [Related]
2. Effect of exercise training on A-FABP, lipocalin-2 and RBP4 levels in obese women.
Choi KM; Kim TN; Yoo HJ; Lee KW; Cho GJ; Hwang TG; Baik SH; Choi DS; Kim SM
Clin Endocrinol (Oxf); 2009 Apr; 70(4):569-74. PubMed ID: 18710473
[TBL] [Abstract][Full Text] [Related]
3. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease.
Suh JB; Kim SM; Cho GJ; Choi KM
Scand J Gastroenterol; 2014 Aug; 49(8):979-85. PubMed ID: 24957697
[TBL] [Abstract][Full Text] [Related]
4. Adipocytokines mark insulin sensitivity in euthyroid Hashimoto's patients.
Solini A; Dardano A; Santini E; Polini A; Monzani F
Acta Diabetol; 2013 Feb; 50(1):73-80. PubMed ID: 22639339
[TBL] [Abstract][Full Text] [Related]
5. Weight loss in prepubertal obese children is associated with a decrease in adipocyte fatty-acid-binding protein without changes in lipocalin-2: a 2-year longitudinal study.
Corripio R; Gónzalez-Clemente JM; Pérez-Sánchez J; Näf S; Gallart L; Nosàs R; Vendrell J; Caixàs A
Eur J Endocrinol; 2010 Dec; 163(6):887-93. PubMed ID: 20870707
[TBL] [Abstract][Full Text] [Related]
6. Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease.
Choi KM; Lee JS; Kim EJ; Baik SH; Seo HS; Choi DS; Oh DJ; Park CG
Eur J Endocrinol; 2008 Feb; 158(2):203-7. PubMed ID: 18230827
[TBL] [Abstract][Full Text] [Related]
7. Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation.
Morieri ML; Guardigni V; Sanz JM; Dalla Nora E; Soavi C; Zuliani G; Sighinolfi L; Passaro A
BMC Infect Dis; 2018 Jan; 18(1):10. PubMed ID: 29304747
[TBL] [Abstract][Full Text] [Related]
8. Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease.
Milner KL; van der Poorten D; Xu A; Bugianesi E; Kench JG; Lam KS; Chisholm DJ; George J
Hepatology; 2009 Jun; 49(6):1926-34. PubMed ID: 19475694
[TBL] [Abstract][Full Text] [Related]
9. Lipocalin-2, glucose metabolism and chronic low-grade systemic inflammation in Chinese people.
Huang Y; Yang Z; Ye Z; Li Q; Wen J; Tao X; Chen L; He M; Wang X; Lu B; Zhang Z; Zhang W; Qu S; Hu R
Cardiovasc Diabetol; 2012 Jan; 11():11. PubMed ID: 22292925
[TBL] [Abstract][Full Text] [Related]
10. Effect of lifestyle modification on serum chemerin concentration and its association with insulin sensitivity in overweight and obese adults with type 2 diabetes.
Kim SH; Lee SH; Ahn KY; Lee DH; Suh YJ; Cho SG; Choi YJ; Lee DH; Lee SY; Hong SB; Kim YS; Jeon JY; Nam M
Clin Endocrinol (Oxf); 2014 Jun; 80(6):825-33. PubMed ID: 23682797
[TBL] [Abstract][Full Text] [Related]
11. Estimation of tissue and serum lipocalin-2 in psoriasis vulgaris and its relation to metabolic syndrome.
El-Hadidi H; Samir N; Shaker OG; Otb S
Arch Dermatol Res; 2014 Apr; 306(3):239-45. PubMed ID: 24052155
[TBL] [Abstract][Full Text] [Related]
12. Non-traditional adipokines in pediatric HIV-related lipodystrophy: a-FABP as a biomarker of central fat accumulation.
Theodoridou K; Margeli A; Spoulou V; Bathrellou I; Skevaki C; Chrousos GP; Papassotiriou I; Kanaka-Gantenbein C
Scand J Clin Lab Invest; 2014 Jan; 74(1):67-73. PubMed ID: 24266781
[TBL] [Abstract][Full Text] [Related]
13. Lipocalin-2: development, analytical characterization, and clinical testing of a new ELISA.
Stejskal D; Karpísek M; Humenanska V; Hanulova Z; Stejskal P; Kusnierova P; Petzel M
Horm Metab Res; 2008 Jun; 40(6):381-5. PubMed ID: 18393169
[TBL] [Abstract][Full Text] [Related]
14. Olmesartan reduces arterial stiffness and serum adipocyte fatty acid-binding protein in hypertensive patients.
Miyoshi T; Doi M; Hirohata S; Kamikawa S; Usui S; Ogawa H; Sakane K; Izumi R; Ninomiya Y; Kusachi S
Heart Vessels; 2011 Jul; 26(4):408-13. PubMed ID: 21063874
[TBL] [Abstract][Full Text] [Related]
15. The relationship between inflammation and arterial stiffness in patients with essential hypertension.
Kampus P; Muda P; Kals J; Ristimäe T; Fischer K; Teesalu R; Zilmer M
Int J Cardiol; 2006 Sep; 112(1):46-51. PubMed ID: 16297996
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of the adipokine lipocalin-2 are increased in preeclampsia.
Stepan H; Philipp A; Reiche M; Klostermann K; Schrey S; Reisenbüchler C; Lossner U; Kratzsch J; Bluher M; Stumvoll M; Fasshauer M
J Endocrinol Invest; 2010 Oct; 33(9):629-32. PubMed ID: 20208456
[TBL] [Abstract][Full Text] [Related]
17. Circulating resistin levels in essential hypertension.
Furuhashi M; Ura N; Higashiura K; Murakami H; Shimamoto K
Clin Endocrinol (Oxf); 2003 Oct; 59(4):507-10. PubMed ID: 14510915
[TBL] [Abstract][Full Text] [Related]
18. Plasma lipocalin-2 levels in pregnancy.
Cesur S; Yucel A; Noyan V; Sagsoz N
Acta Obstet Gynecol Scand; 2012 Jan; 91(1):112-116. PubMed ID: 21504415
[TBL] [Abstract][Full Text] [Related]
19. Circulating levels of lipocalin-2 and retinol-binding protein-4 are increased in psoriatic patients and correlated with baseline PASI.
Romaní J; Caixàs A; Ceperuelo-Mallafré V; Carrascosa JM; Ribera M; Rigla M; Vendrell J; Luelmo J
Arch Dermatol Res; 2013 Mar; 305(2):105-12. PubMed ID: 23242471
[TBL] [Abstract][Full Text] [Related]
20. The lipocalins retinol-binding protein-4, lipocalin-2 and lipocalin-type prostaglandin D2-synthase correlate with markers of inflammatory activity, alcohol intake and blood lipids, but not with insulin sensitivity in metabolically healthy 58-year-old Swedish men.
Wallenius V; Elias E; Bergstrom GM; Zetterberg H; Behre CJ
Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):75-80. PubMed ID: 21104585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
